Kwang Dong Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
₩187.29B ₩216.00B ₩208.43B ₩250.52B ₩276.17B ₩276.59B ₩289.69B ₩313.99B ₩332.64B ₩468.38B ₩522.27B ₩955.45B ₩1.06T ₩1.14T ₩1.18T ₩1.24T ₩1.24T ₩1.34T ₩1.43T ₩1.51T ₩0.00M
GM % Gross Margin %
39.47% 42.04% 43.62% 43.64% 43.48% 42.88% 43.82% 42.99% 40.14% 35.94% 36.52% 24.12% 23.24% 21.44% 20.29% 20.72% 20.59% 20.35% 19.56% 19.67% 0.00%
OM Operating Margin
11.20% 12.48% 11.05% 11.86% 10.92% 11.18% 13.52% 12.87% 10.92% 9.48% 9.66% 5.32% 4.20% 3.13% 2.88% 3.38% 3.75% 3.36% 2.67% 2.78% 0.00%
EPS Earnings Per Share
₩663.00 ₩640.00 ₩523.00 ₩827.00 ₩719.00 ₩719.00 ₩0.00
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩70.00 ₩0.00 ₩80.00 ₩80.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩80.00 ₩0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 13.38% 0 9.67% 11.13% 0 0 0 0 0 0 11.13% 0
Sha. Shares
50.42m 50.42m 49.58m 49.6m 47.58m 46.64m 44.64m 44.64m 42.64m 40.98m 40.03m 40.45m 40.58m 40.58m 40.58m 39.58m 41.08m 41.08m 41.08m 40.08m 40.08m
OCF Operating Cash Flow
₩30.71B ₩34.00B ₩18.95B ₩36.26B ₩16.31B ₩26.28B ₩30.50B ₩27.75B ₩23.74B ₩34.39B ₩32.75B ₩41.14B ₩28.80B ₩23.46B ₩53.10B ₩29.29B ₩22.83B ₩54.94B ₩62.82B ₩-11730.41M ₩0.00M
FCF Free Cash Flow
₩10.26B ₩23.34B ₩1.12B ₩26.45B ₩8.70B ₩20.85B ₩20.01B ₩-443.18M ₩-7504.08M ₩26.29B ₩14.34B ₩-2676.74M ₩13.25B ₩9.39B ₩34.27B ₩16.65B ₩17.57B ₩31.14B ₩37.44B ₩-18378.25M ₩0.00M
FCFS Free Cash Flow Per Share
₩199.23 ₩463.03 ₩22.59 ₩535.73 ₩180.32 ₩440.85 ₩438.25 ₩-11.01 ₩-180.64 ₩670.22 ₩355.14 ₩329.21 ₩270.57 ₩132.46 ₩836.94 ₩419.06 ₩432.44 ₩742.27 ₩896.35 ₩-1157.55 ₩0.00